What are Semaglutide, Tirzepatide, and Retatrutide?

What are Semaglutide, Tirzepatide, and Retatrutide?

All three of these medications are part of a new generation of metabolic therapies originally developed for diabetes and obesity. They work by mimicking or amplifying gut hormones that help regulate appetite, blood sugar, and how the brain responds to food.

• Semaglutide – A GLP‑1 receptor agonist.
• Tirzepatide – A dual GIP/GLP‑1 receptor agonist.
• Retatrutide – An emerging triple agonist (GLP‑1, GIP, and glucagon receptors) currently under active study and not FDA-approved for weight loss or general wellness; at Better Med Spa it is available only under a non‑FDA waiver.

These medications can be very effective for both blood sugar control and weight reduction in appropriate patients, but they also come with potential risks and side effects and must be prescribed and monitored by licensed medical professionals.

‍

How semaglutide works

Semaglutide acts like a hormone called GLP‑1, which is naturally released from your gut when you eat. By activating GLP‑1 receptors more strongly and for longer, semaglutide:

• Slows gastric emptying (food leaves your stomach more slowly).
• Helps your pancreas release insulin in a glucose-dependent way.
• Reduces glucagon secretion.
• Sends stronger “I’m full” signals to the brain.

For many patients, this leads to smaller portions feeling satisfying, fewer cravings, improved blood sugar control, and gradual weight loss when combined with dietary changes and movement. It is FDA‑approved at specific doses and brand names for type 2 diabetes and chronic weight management in defined populations when combined with lifestyle interventions.

‍

How tirzepatide is different

Tirzepatide is often described as a “dual agonist” because it targets two hormone systems: GLP‑1 and GIP (glucose‑dependent insulinotropic polypeptide). By acting on both receptors, it:

• Enhances insulin secretion when blood sugar is high.
• Suppresses glucagon when appropriate.
• Modulates appetite and fullness signals.
• Appears to have a strong effect on body weight in many patients.

Tirzepatide is FDA‑approved for specific indications, including type 2 diabetes and, at certain doses and brand names, chronic weight management in adults with defined BMI criteria plus at least one weight-related condition, when combined with lifestyle change. In practice, some patients respond to tirzepatide with more pronounced weight loss than semaglutide, but individual response varies.

‍

What makes retatrutide different—and why it’s under a non-FDA waiver

Retatrutide is a newer “triple agonist,” targeting GLP‑1, GIP, and glucagon receptors. Early clinical trials suggest it may have very potent effects on weight and metabolic markers, but:

• It is not FDA‑approved for weight loss or general wellness.
• Long-term safety data are still being collected.
• Optimal dosing, duration, and patient selection are still under investigation.

Because of this, at Better Med Spa:

• Retatrutide is offered only under a non‑FDA waiver, meaning it is explicitly recognized as experimental off‑label use for wellness/weight-management indications.
• Patients receive detailed counseling about the limits of current evidence, potential risks, and alternative options.
• It is reserved for carefully selected individuals who fully understand that they are choosing an emerging therapy.

This is not a casual or “first step” option; it’s for people who have had thoughtful discussions with a provider about risks, benefits, and unknowns.

‍

Comparing semaglutide, tirzepatide, and retatrutide

Semaglutide

• Main Mechanism: GLP-1 Agonist
• FDA Status: Approved for specific diabetes and obesity indications at specific doses
• Administration: Typically weekly injection (varies by formulation)
• Typical Goals: Appetite reduction, weight loss, metabolic support

Tirzepatide

• Main Mechanism: GLP + GLP-1 Dual Agonist
• FDA Status: Approved for specific diabetes and obesity indications at specific doses
• Administration: Typically weekly injection
• Typical Goals: Similar goals; often more potent in some patients

Retatrutide

• Main Mechanism: GLP + GLP-1 + Glucagon Triple Agonist
• FDA Status: Not FDA‑approved for weight loss or wellness; offered only under non‑FDA waiver
• Administration: Investigational; protocols vary and are evolving (typically weekly)
• Typical Goals: Exploring enhanced weight/metabolic effects (experimental)

‍

Common benefits—and what they depend on

Patients often pursue these medications for:

• Meaningful, sustainable weight loss.
• Better control of type 2 diabetes (when used in a medical context; some patients may already be under endocrine care).
• Reduced cravings and emotional or “compulsive” eating.
• Improved markers like A1C, fasting glucose, and certain cardiovascular risk factors.

But all of these improvements are:

• Highly individual.
• Strongly influenced by nutrition, movement, sleep, stress, and existing medications.
• Dependent on correct use, appropriate dose, and adequate monitoring.

No injectable replaces healthy eating, movement, or care from your primary doctor or specialist. At Better Med Spa, these medications are framed as tools, not cures.

‍

Side effects and safety considerations

The most common side effects across GLP‑1/GIP/glucagon agonists include:

• Nausea, vomiting, or reduced appetite that feels “too strong.”
• Diarrhea or constipation.
• Bloating, heartburn, or abdominal discomfort.
• Fatigue or feeling “off” while the body adjusts.

More serious potential risks include (not an exhaustive list):

• Pancreatitis.
• Gallbladder issues (gallstones, inflammation).
• Worsening of certain pre‑existing digestive conditions.
• Possible impact on certain eye conditions in people with diabetes.
• Unknown long-term effects, especially for newer agents like retatrutide.

People with specific histories—such as medullary thyroid carcinoma, MEN 2, certain pancreatic or gallbladder diseases—may not be appropriate candidates. That’s why these medications should only be used under the guidance of a licensed clinician who reviews your history, medications, and lab work.

‍

How Better Med Spa approaches these medications

1. Medical evaluation first

Before starting semaglutide, tirzepatide, or retatrutide, you’ll complete:

• A comprehensive intake and medical history.
• Review of current medications and supplements.
• Baseline measurements (weight, blood pressure, sometimes labs as appropriate).

This helps determine if you’re a candidate and which medication and dose makes sense.

2. Clear framing and informed consent

You’ll discuss:

• FDA-approved indications and what is off-label.
• Expected benefits vs what’s unknown.
• Side effects, red-flag symptoms, and when to call the office or seek urgent care.
• The non‑FDA-waiver status of retatrutide, and what that means in practical terms.

Nothing is started without your fully informed consent.

3. Slow, structured titration

Doses are typically started low and increased gradually to reduce side effects and allow your body to adjust. Rushing titration is one of the biggest reasons people feel terrible on these medications.

4. Lifestyle integration

Our team will encourage you to use the “appetite quiet” these medications often provide to:

• Learn what proper portions look like for your body.
• Focus on protein, fiber, and nutrient-dense foods.
• Build realistic movement into your week.
• Address sleep and stress—both of which affect weight and metabolic health.

The goal is that, even if you eventually taper off the medication, you keep the habits that support your weight and wellbeing.

5. Regular follow-ups and adjustments

Follow-ups are scheduled to:

• Monitor side effects and tolerability.
• Adjust dose up or down as needed.
• Decide when to pause, maintain, or taper.
• Reassess whether continuing therapy still makes sense for your body and goals.

For retatrutide specifically, follow-up and monitoring are especially important because the evidence base is still evolving.

‍

Who might be a good candidate?

You may be a good candidate to discuss these medications if:

• You meet BMI and/or metabolic criteria commonly used in medical weight management.
• You’ve already tried structured lifestyle changes and still struggle.
• You are under the care of a primary physician and/or specialist if you have conditions like diabetes, heart disease, or kidney disease.
• You’re willing to have labs and regular follow-ups.
• You understand these medications are not cosmetic quick fixes but medical tools.

You may not be a good candidate if you:

• Have a disordered eating history that could be worsened by aggressive appetite suppression.
• Are pregnant, breastfeeding, or planning pregnancy soon.
• Have specific endocrine, pancreatic, or gastrointestinal diseases that make these medications too risky.
• Want a “set it and forget it” solution and aren’t interested in lifestyle change or follow-up.

These questions are exactly what the consultation is designed to sort out.

‍

FAQs: Semaglutide, Tirzepatide, and Retatrutide

Will I be on these medications forever?
Not necessarily. Some patients stay on long term under medical supervision; others use them for a finite period while building new habits. Stopping suddenly can lead to weight regain if no lifestyle groundwork has been laid.

Can I choose which one I want?
You can discuss preferences, but the final decision is a shared medical decision based on your health history, goals, finances, and risk tolerance—especially for an emerging therapy like retatrutide.

Is retatrutide “stronger” or “better”?
Early data suggest it may have very potent effects, but “stronger” doesn’t automatically mean “better” or “safer” for everyone. Until more long-term evidence is available, it should be approached conservatively and only with full understanding of its non‑FDA, experimental status in wellness contexts.

Can I drink alcohol on these medications?
Best to keep alcohol minimal and discuss specifics with your provider; both alcohol and these injectables can affect the pancreas and liver.

‍

A thoughtful path forward in Lincoln Park, Chicago

Powerful tools demand thoughtful use. At Better Med Spa, semaglutide, tirzepatide, and retatrutide are never treated as trendy “shots,” but as serious medications that can help the right person when layered onto an honest, realistic plan for health.

If you’re in Lincoln Park or anywhere in the Chicago area and want to know whether one of these options belongs in your journey, the next step is a medical consultation. You’ll get space to ask questions, talk through your history, and understand which medication, if any, makes sense for your body, your lifestyle, and your long-term goals.

‍

The content provided on this blog is for educational purposes only and does not substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of your healthcare provider for any questions regarding your health or medical conditions. We strive to present accurate and up-to-date information, but outcomes and experiences may vary. Our med spa is not responsible for any actions taken based on this blog. If treatments, products, or procedures are mentioned, please consult with a licensed professional to determine if they are appropriate for you.